Kallikrein 2 Antikörper (Internal Region)
Kurzübersicht für Kallikrein 2 Antikörper (Internal Region) (ABIN190842)
Target
Alle Kallikrein 2 (KLK2) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Bindungsspezifität
- Internal Region
-
Verwendungszweck
- KLK2
-
Sequenz
- KHQSLRPDED SSHD
-
Spezifität
- This antibody is expected to recognize both reported isoforms (NP_005542.1, NP_001002231.1).
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
Immunogen
- Peptide with sequence C-KHQSLRPDEDSSHD, from the internal region of the protein sequence according to NP_005542.1, NP_001002231.1.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Immunohistochemistry: Paraffin embedded Human Prostate. Recommended concentration: 2.5-8 μg/mL.
Western Blot: Approx 26 kDa band observed in lysates of cell line HeLa, which was successfully blocked by incubation with the immunizing peptide (calculated MW of 28.7 according to NP_005542.1 and 24.7 kDa according to NP_001002231.1 ). Recommended concen
Peptide ELISA: antibody detection limit dilution 1:64000.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Minimize freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
- Kallikrein 2 (KLK2)
-
Andere Bezeichnung
- KLK2
-
Hintergrund
- KLK2, kallikrein-related peptidase 2, KLK2A2, MGC12201, hK2 , glandular kallikrein 2, kallikrein 2, prostatic
-
Gen-ID
- 3817
-
NCBI Accession
- NP_005542, NP_001002231
-
Pathways
- Komplementsystem
Target
-